Should Cellulitis with Weeping Be Treated as Purulent?
No, weeping cellulitis should NOT be automatically treated as purulent cellulitis—the presence of serous drainage alone does not indicate purulent infection and does not warrant MRSA coverage in typical cases.
Key Distinction: Weeping vs. Purulent Drainage
The critical factor is the character of the drainage, not simply its presence:
- Weeping/serous drainage = clear or straw-colored fluid from edematous tissue (non-purulent)
- Purulent drainage = thick, opaque, pus-like material (purulent)
This distinction fundamentally changes antibiotic selection.
Treatment Algorithm Based on Drainage Character
For Non-Purulent Cellulitis (Including Weeping):
First-line therapy should target streptococci 1:
- Oral options: penicillin, amoxicillin, cephalexin, or dicloxacillin
- Duration: 5 days if clinical improvement occurs 1
- MRSA coverage is NOT needed for typical non-purulent cellulitis 1
The evidence strongly supports this approach: a prospective study showed β-lactams (cefazolin/oxacillin) were successful in 96% of cellulitis cases, demonstrating MRSA is an uncommon cause 1. A randomized trial confirmed that adding SMX-TMP to cephalexin provided no additional benefit over cephalexin alone in pure cellulitis 1.
Add MRSA Coverage ONLY When These Specific Features Are Present:
Indications for dual coverage (streptococci + MRSA) 1:
- Purulent drainage (actual pus, not serous fluid)
- Penetrating trauma, especially injection drug use
- Evidence of MRSA infection elsewhere
- Known MRSA nasal colonization
- Systemic inflammatory response syndrome (SIRS)
For these cases, use 1:
- Clindamycin alone (covers both), OR
- SMX-TMP or doxycycline PLUS a β-lactam (penicillin/cephalexin/amoxicillin)
Common Pitfall to Avoid
Do not conflate edema-related weeping with purulent infection. Weeping in cellulitis typically represents serous fluid from inflamed, edematous tissue—this is a manifestation of the inflammatory process, not an indicator of S. aureus or MRSA involvement 2, 3. The majority of non-purulent cellulitis cases are caused by β-hemolytic streptococci or methicillin-sensitive S. aureus, both adequately covered by β-lactams 2, 4.
Additional Management Considerations
Beyond antibiotics 1:
- Elevate the affected area to promote drainage of edema
- Examine interdigital toe spaces for tinea pedis/fissuring and treat if present
- Address underlying venous insufficiency or lymphedema
- Consider 7-day course of prednisone 40 mg daily in non-diabetic adults (may hasten resolution) 1
When to Reassess
If no improvement within 5 days on appropriate β-lactam therapy, then consider 1, 4:
- Resistant organisms (including MRSA)
- Misdiagnosis (venous stasis dermatitis, DVT, contact dermatitis)
- Underlying complications (immunosuppression, deeper infection)
The bottom line: Treat weeping cellulitis as non-purulent cellulitis with β-lactam monotherapy unless specific risk factors for MRSA are present 1, 2, 3.